During the past decade, Medicana International Ankara Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Medicana International Ankara Hospital" are "Atrial Fibrillation and Flutter" (1 trials), "Thrombotic Stroke" (1 trials) and "Veno-occlusive Disease" (1 trials). Many other conditions were trialed in "Medicana International Ankara Hospital" in a lesser frequency.

Most popular intervention types in "Medicana International Ankara Hospital" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Best Supportive Care" (1 trials) and "Defibrotide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medicana International Ankara Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Medicana International Ankara Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Medicana International Ankara Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medicana International Ankara Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".